Cargando…
Discovery of N-(2-Aminophenyl)-4-(bis(2-chloroethyl)amino)Benzamide as a Potent Histone Deacetylase Inhibitor
Inhibition of histone deacetylases (HDACs) has been an important emerging therapy for the treatment of multiple cancers. However, the application of HDAC inhibitors is restricted by the limited potency against solid tumors. In order to discover novel HDAC inhibitors with potent antitumor activities,...
Autores principales: | Zhang, Lihui, Li, Xiaoyang, Chen, Yiming, Wan, Minghui, Jiang, Qixiao, Zhang, Li, Chou, C. James, Song, Weiguo, Zhang, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6730478/ https://www.ncbi.nlm.nih.gov/pubmed/31543818 http://dx.doi.org/10.3389/fphar.2019.00957 |
Ejemplares similares
-
Discovery of N-(2-Amino-4-Fluorophenyl)-4-[bis-(2-Chloroethyl)-Amino]-Benzamide as a Potent HDAC3 Inhibitor
por: Chen, Yiming, et al.
Publicado: (2020) -
Discovery of indole-3-butyric acid derivatives as potent histone deacetylase inhibitors
por: Chen, Yiming, et al.
Publicado: (2021) -
Zinc binding groups for histone deacetylase inhibitors
por: Zhang, Lei, et al.
Publicado: (2018) -
tert-Butyl N-[N,N-bis(2-chloroethyl)sulfamoyl]-N-(2-chloroethyl)carbamate
por: Seridi, Achour, et al.
Publicado: (2009) -
Dichlorophosphinic bis(2-chloroethyl)amide
por: Song, Erqun, et al.
Publicado: (2012)